Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal

Core Insights - Metsera's shareholders may receive substantial bonuses contingent upon the achievement of specific milestones [1] Summary by Categories - Shareholder Benefits - Significant bonuses for shareholders are linked to the attainment of certain milestones [1]